Showing results (211-220 of 363) with videos related to

Sort By:
Pageof 37
Journal of Virology|November 2, 2001
Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous systemT H Wang, Y K Donaldson, R P Brettle, et al.
The Journal of Infectious Diseases|June 1, 1993
Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeonE C Holmes, L Q Zhang, P Simmonds, et al.
The Journal of Infectious Diseases|April 7, 1999
Early acquisition of TT virus (TTV) in an area endemic for TTV infectionF Davidson, D MacDonald, J L Mokili, et al.
Biochemical and Biophysical Research Communications|July 9, 1997
The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South AfricaR W Chamberlain, N J Adams, L A Taylor, et al.
The Journal of General Virology|March 18, 2008
Widespread recombination within human parechoviruses: analysis of temporal dynamics and constraintsK S M Benschop, Ç H Williams, K C Wolthers, et al.
Journal of Clinical Microbiology|June 18, 2010
Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR methodE R Gaunt, A Hardie, E C J Claas, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 4, 2009
Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitorsP L F Giangrande, J T Wilde, B Madan, et al.
Thrombosis Research|January 4, 2011
EUHASS: The European Haemophilia Safety Surveillance systemM Makris, G Calizzani, K Fischer, et al.
Circulation|April 18, 2001
Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosisD E Newby, A L McLeod, N G Uren, et al.
Heart (British Cardiac Society)|December 26, 2001
Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivoD E Newby, F N Witherow, R A Wright, et al.
Pageof 37